TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Dala Vård & Vaccin AB
Closing information (x1000 NOK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
14,400
|
13,043
|
7,098 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
1,117
|
2,173
|
278 |
EBITDA |
1,151
|
2,256
|
360 |
Total assets |
3,089
|
3,554
|
1,478 |
Current assets |
2,745
|
3,163
|
1,039 |
Current liabilities |
1,503
|
1,591
|
1,078 |
Equity capital |
1,413
|
1,848
|
400 |
- share capital |
60
|
62
|
57 |
Employees (average) |
5
![]() |
5
|
4 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
45.7%
|
52.0%
|
27.1% |
Turnover per employee |
2,880
|
2,609
|
1,774 |
Profit as a percentage of turnover |
7.8%
|
16.7%
|
3.9% |
Return on assets (ROA) |
36.2%
|
61.1%
|
18.8% |
Current ratio |
182.6%
|
198.8%
|
96.4% |
Return on equity (ROE) |
79.1%
|
117.6%
|
69.5% |
Change turnover |
1,751
|
5,326
|
419 |
Change turnover % |
14%
|
69%
|
6% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
25%
|
33% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.